SECURITIES AND EXCHANGE COMMISSION
                                   WASHINGTON, D.C.

     Litigation Release No. 15456 August 21, 1997

     SECURITIES AND EXCHANGE COMMISSION v. ROBERT J. YOUNG, WILLIAM
DOUGLAS
     MORGAN, RUSSELL LOZIS AND BETH LOMBARDO, 3:95 CV 2106 (AHN) (D.
CONN.)

          The Commission announced today that on July 15, 1997, the U.S.
     District Court for the District of Connecticut entered final consent
     judgments against Defendants Russell Lozis ("Lozis"), 49, and Beth
Lombardo
     ("Lombardo"), 42, the last two remaining defendants in this civil
     injunctive action alleging unlawful insider trading.  The Complaint
alleges
     that Lozis and Lombardo, a married couple residing in East Hampton,
     Connecticut, among others, purchased stock in MedImmune, Inc.
("MedImmune")
     while in possession of material, nonpublic information concerning a
     proposed collaboration agreement between MedImmune and Merck, Inc. to
     develop an immunotherapy and vaccine for the virus that causes AIDS
using
     MedImmune's monoclonal antibody technology.

          Lozis and Lombardo, without admitting or denying the allegations
of
     the Complaint, each consented to the entry of a final judgment
permanently
     enjoining them from future violations of Section 10(b) of the
Securities
     Exchange Act of 1934 ("Exchange Act") and Rule 10b-5.  Lozis agreed to
pay
     a total of $11,807.26 in disgorgement and prejudgment interest;
however,
     payment of such amount was waived, and no civil penalty imposed, based
upon
     his demonstrated inability to pay.  Lombardo consented to pay a total
of
     $2,565.03 in disgorgement and prejudgment interest.

          Final consent judgments previously were entered against
Defendants
     Robert J. Young ("Young") and William Douglas Morgan ("Morgan").  Young
and